
Lenvat contains Lenvatinib 10mg, a targeted therapy used in the treatment of thyroid cancer, kidney cancer (renal cell carcinoma), and liver cancer (hepatocellular carcinoma).
| Generic Name | Lenvatinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Capsules |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




| Package | USD | GBP | AUD | NZD | PHP | KRW | RON | HKD | MYR | THB | AED |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 30 Capsules | $160 | £119 | A$224 | NZ$278 | ₱10,036 | ₩218,854 | lei 734 | HK$1,255 | RM645 | ฿5,320 | د.إ588 |
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.